Ryan D.

Ryan D. has a diverse work experience spanning several industries and roles. Ryan started their career as a Research Technician at NC State University in 1996. Ryan then worked as a Research Assistant at GlaxoSmithKline in 2001. Ryan pursued their graduate studies at the University of North Carolina at Chapel Hill from 2003 to 2008. Following this, they worked as a Postdoctoral Research Associate at the National Institute of Environmental Health Sciences, where they focused on studying the role of eicosanoids in cardiovascular and respiratory diseases.

Ryan then transitioned into the pharmaceutical industry and joined Nuventra Pharma Sciences in 2011. Here, they held various roles, including Business Operations Associate, Clinical Pharmacology Associate, Manager of Business Operations, and Senior Manager of Business Operations. In these positions, Ryan contributed to the development of clinical protocols, study reports, and regulatory documents, while also providing support to pharmacokineticists and clinical pharmacology consultants.

In 2015, Ryan briefly worked as a Research Scientist at the Medical University of South Carolina. Ryan then returned to Nuventra Pharma Sciences and served as an Associate Director and Director of Contracts and Proposals, where they managed proposal development and budgeting for new business opportunities.

In 2022, Ryan joined Certara as a Clinical Scientist, providing scientific input into clinical trial study design and supporting the writing of clinical technical documents.

Ryan's most recent position is as the Director of Clinical Operations at Grid Therapeutics, where they oversee the operational aspects of clinical trials.

Overall, Ryan D. has a strong background in clinical research and operations within the pharmaceutical industry, with experience in proposal development, study design, and regulatory document preparation.

Ryan D. received a B.S. in Zoology from North Carolina State University in 2000. Ryan continued their education at the University of North Carolina at Chapel Hill, where they earned a Ph.D. in Genetics and Molecular Biology in 2008. In 2022, they obtained certifications in Fundamentals of Pharmacokinetics and Noncompartmental Data Analysis from Certara.